Signaling Pathways - MST - Hck - Adenosine A2B Receptors - Akt
清除全部
-
A8735 XMU-MP-12 CitationTarget: MSTSummary: MST1/2的强效选择性抑制剂 -
B6099 LY3023414Target: Akt|PI3K|mTOR|DNA-PKSummary: I类PI3K，mTOR和DNA-PK抑制剂 -
B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂 -
B7105 10-DEBC hydrochlorideTarget: AktSummary: Akt抑制剂 -
B2180 AS-252424Target: Akt|PI3KSummary: PI3Kγ抑制剂 -
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂 -
A8617 CCT128930 HClTarget: AktSummary: AKT抑制剂 -
A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂 -
A8499 PF-04691502Target: Akt|PI3K|mTORSummary: PI3K/mTOR (FRAP)抑制剂 -
A8309 Perifosine1 Citation中文名: 哌立福新Target: AktSummary: Akt抑制剂